Correction: High-Dose Chemotherapy Followed by Autologous Stem Cell Transplantation as a First-Line Therapy for High-Risk Primary Breast Cancer: A Meta-Analysis

Bibliographic Details
Main Authors:	Jing Wang, Qiguo Zhang, Rongfu Zhou, Bing Chen, Jian Ouyang
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2012-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3553191/?tool=EBI

Correction: High-Dose Chemotherapy Followed by Autologous Stem Cell Transplantation as a First-Line Therapy for High-Risk Primary Breast Cancer: A Meta-Analysis.
by: Jing Wang, et al.
Published: (2012-01-01)

High-dose chemotherapy followed by autologous stem cell transplantation as a first-line therapy for high-risk primary breast cancer: a meta-analysis.
by: Jing Wang, et al.
Published: (2012-01-01)

The effectiveness of high-dose chemotherapy with autologous hematopoietic stem cell transplantation in the treatment
by: T. V. Yukhta, et al.
Published: (2019-12-01)

High-dose chemotherapy followed by autologous stem cell transplantation for metastatic rhabdomyosarcoma--a systematic review.
by: Frank Peinemann, et al.
Published: (2011-01-01)

High dose chemotherapy with autologous stem cell transplantation in diffuse large B-cell lymphoma
by: Popp, Henning, et al.
Published: (2007-06-01)

High-dose chemotherapy followed by autologous stem cell transplant for multiple myeloma: Predictors of long-term outcome
by: Lalit Kumar, et al.
Published: (2019-01-01)

Brazilian experience using high dose sequential chemotherapy followed by autologous hematopoietic stem cell transplantation for malignant lymphomas
by: Bruno Kosa Lino Duarte, et al.
Published: (2011-12-01)

Successful Treatment with High-Dose Chemotherapy Followed by Autologous Stem-Cell Transplantation in a Patient with Metastatic Germ Cell Tumor
by: Jung Min Lee, et al.
Published: (2021-06-01)

Role of high-dose chemotherapy and autologous stem cell transplantation in patients with diffuse large B-cell lymphoma
by: O A Gavrilina, et al.
Published: (2013-07-01)

Associations of Ficolins With Hematological Malignancies in Patients Receiving High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantations
by: Anna S. Świerzko, et al.
Published: (2020-01-01)

Long-term survival after high-dose chemotherapy with autologous hematopoietic cell transplantation in metastatic breast cancer
by: Betty Ky Hamilton, et al.
Published: (2015-09-01)

High-dose chemotherapy following autologous hematopoietic stem cell transplantation for multiple myeloma in the real world setting. Single-center experience
by: Nikita E. Mochkin, et al.
Published: (2020-07-01)

Post-treatment work patterns amongst survivors of lymphoma treated with high-dose chemotherapy with autologous stem-cell transplantation
by: Kjersti Helene Hernæs, et al.
Published: (2021-02-01)

Age-adjusted high-dose chemotherapy and autologous stem cell transplant in elderly and fit primary CNS lymphoma patients
by: Elisabeth Schorb, et al.
Published: (2019-03-01)

Biochemical Markers of Cardiotoxicity of High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation in Patients with Malignant Lymphoproliferative Disorders
by: VO Sarzhevskii, et al.
Published: (2016-10-01)

Infectious Complications during Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Children with High-Risk or Recurrent Solid Tumors.
by: Young Bae Choi, et al.
Published: (2016-01-01)

Prognostic Value of EMT-Circulating Tumor Cells in Metastatic Breast Cancer Patients Undergoing High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation
by: Michal Mego, Hui Gao, Bang-Ning Lee, Evan N. Cohen, Sanda Tin, Antonio Giordano, Qiong Wu, Ping Liu, Yago Nieto, Richard E. Champlin, Gabriel N. Hortobagyi, Massimo Cristofanilli, Naoto T. Ueno, James M. Reuben
Published: (2012-01-01)

Reduction in incidence of early fatal complications of high-dose chemotherapy with autologous hematopoietic stem cell transplantation in Hodgkin lymphoma patients
by: N. V. Zhukov, et al.
Published: (2014-07-01)

Role of Positron-Emission Tomography in Prognosis of Outcomes of High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation in Hodgkin’s Lymphoma
by: VG Potapenko, et al.
Published: (2016-10-01)

High-dose chemotherapy and autologous peripheral blood stem cell transplantation in the treatment of children and adolescents with Ewing sarcoma family of tumors
by: Juhee Seo, et al.
Published: (2013-09-01)

Reduction in incidence of early fatal complications of high-dose chemotherapy with autologous hematopoietic stem cell transplantation in Hodgkin lymphoma patients
by: N. V. Zhukov, et al.
Published: (2014-07-01)

Incorporation of high-dose 131I-metaiodobenzylguanidine treatment into tandem high-dose chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma: results of the SMC NB-2009 study
by: Ji Won Lee, et al.
Published: (2017-05-01)

Successful Treatment of Osteosarcoma Arising in Osteogenesis Imperfecta with High-Dose Chemotherapy and Autologous Peripheral Blood Stem Cell Transplantation Followed-by Limb Sparing Surgery
by: Selmin Ataergin, et al.
Published: (2007-01-01)

High dose chemotherapy and autologous stem cell transplantation in relapsed or refractory Hodgkin lymphoma: Emerging questions, newer agents, and changing paradigm
by: Saad Akhtar
Published: (2017-12-01)

Long-Term Remission in a Case of Anaplastic Thyroid Carcinoma following Local Irradiation and High-Dose Chemotherapy with Autologous Peripheral Blood Stem Cell Transplantation
by: Koji Kato, et al.
Published: (2007-01-01)

High Dose Chemotherapy followed by Autologous Peripheral Stem Cell Transplantation in Patients with Metastatic Cancer and Hematological Malignancy — A Single Institute’s Experience and Result Analysis
by: Yu-Chieh Su, et al.
Published: (2003)

High dose chemotherapy and autologous stem cell transplantation in Multiple Myeloma patients over 70 years: “GIMEMA Working Group Lazio experience
by: A. Rago, et al.
Published: (2020-09-01)

Intensive Care Outcomes of Patients after High Dose Chemotherapy and Subsequent Autologous Stem Cell Transplantation: A Retrospective, Single Centre Analysis
by: Panagiotis Karagiannis, et al.
Published: (2020-06-01)

High-dose chemotherapy followed by stem cell transplantation in the management of retinoblastoma: a systematic review
by: Imad Jaradat, et al.
Published: (2012-04-01)

Use of high-dosage chemotherapy with autologous hematopoietic stem cell transplantation as a first-line therapy for the patients with poor-prognosis testicular tumors
by: Marjanović Slobodan, et al.
Published: (2005-01-01)

Altered T-Lymphocyte Biology Following High-Dose Melphalan and Autologous Stem Cell Transplantation With Implications for Adoptive T-Cell Therapy
by: Thomas Mika, et al.
Published: (2020-12-01)

Impact of Mantle Cell Lymphoma Contamination of Autologous Stem Cell Grafts on Outcome after High-Dose Chemotherapy
by: Malte Roerden, et al.
Published: (2021-05-01)

Real-Life Experience With First-Line Therapy Bortezomib Plus Melphalan and Prednisone in Elderly Patients With Newly Diagnosed Multiple Myeloma Ineligible for High Dose Chemotherapy With Autologous Stem-Cell Transplantation
by: Gabriele Buda, et al.
Published: (2021-08-01)

The role and place of high-dose immunosuppressive therapy and autologous transplantation of hematopoietic stem cells for autoimmune diseases
by: S V Makarov, et al.
Published: (2016-01-01)

High-dose chemotherapy with autologous peripheral blood stem cell support for recurrent primary AFP-producing intracranial germinoma
by: Ziske, Carsten, et al.
Published: (2003-07-01)

Favorable event free-survival of high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation for higher risk diffuse large B-cell lymphoma in first complete remission
by: Hiroto Kaneko, et al.
Published: (2015-06-01)

Consolidation treatment for high risk solid tumors in children with myeloablative chemotherapy and autologous hematopoietic progenitor stem cell transplantation
by: Alberto Olaya Vargas, et al.
Published: (2013-01-01)

CLINICAL EFFECTIVENESS OF HIGH-DOSE IMMUNOSUPPRESSIVE THERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE SCLEROSIS PATIENTS
by: D. A. Fedorenko, et al.
Published: (2014-12-01)

γ-Herpesvirus load as surrogate marker of early death in HIV-1 lymphoma patients submitted to high dose chemotherapy and autologous peripheral blood stem cell transplantation.
by: Chiara Pratesi, et al.
Published: (2015-01-01)

The Role of Complement Activating Collectins and Associated Serine Proteases in Patients With Hematological Malignancies, Receiving High-Dose Chemotherapy, and Autologous Hematopoietic Stem Cell Transplantations (Auto-HSCT)
by: Anna S. Świerzko, et al.
Published: (2018-09-01)

Correction: High-Dose Chemotherapy Followed by Autologous Stem Cell Transplantation as a First-Line Therapy for High-Risk Primary Breast Cancer: A Meta-Analysis

Similar Items

Similar Items